Adriamycin
Product Images NDC 0143-9371

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Adriamycin (NDC 0143-9371). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Adriamycin Injection Structural Formula (Adriamycin Doxorubicin HCl Injection Novaplus 1)

Chemical structure of Adriamycin (Doxorubicin hydrochloride) showing the molecular formula C27H29N01 11•HCl and molecular weight 579.99. The structure displays the characteristic anthracycline arrangement with attached functional groups.*

FDA Label Image

Figure 1 (Adriamycin Doxorubicin HCl Injection Novaplus 2)

A forest plot chart showing hazard ratios with 95% confidence intervals for six clinical trials comparing doxorubicin (DOXO) to CMF. The trials are listed on the y-axis, and hazard ratio values range on the x-axis from 0 to 2, indicating if DOXO is better or worse than CMF. A vertical dashed line indicates the boundary of non-inferiority with CMF at 1.06. The pooled result from six doxorubicin-based studies is marked with a diamond at the bottom.*

FDA Label Image

Figure 2 (Adriamycin Doxorubicin HCl Injection Novaplus 3)

A forest plot chart showing hazard ratios with 95% confidence intervals from multiple clinical trials labeled NSABP B-15, SECSG 2, ONCOFRANCE, SE Sweden BCG A, NSABC Israel Br0283, and Austrian BCSG 3. The plot compares outcomes with doxorubicin-based treatment versus a comparator, with the horizontal axis ranging from 0 to 2, indicating whether doxorubicin is better or worse than the comparator.*

FDA Label Image

Adriamycin Injection 10 mg/5 mL Label (Adriamycin Doxorubicin HCl Injection Novaplus 4)

Adriamycin 10 mg/5 mL vial label showing brand name and active ingredient (Doxorubicin HCl Injection, USP), strength, and volume. Markings include a lot number, barcode, and a reference to single-use only. The label includes usage instructions and warnings, as well as Hikma Pharmaceuticals USA Inc. as the labeler.*

FDA Label Image

Adriamycin Injection 20 mg/10 mL Label (Adriamycin Doxorubicin HCl Injection Novaplus 5)

Adriamycin drug label showing packaging details. It includes instructions for intravenous use only, mentioning the medication form and dosage. The label also lists Hikma Pharmaceuticals USA Inc. as the labeler and provides storage instructions, regulatory information, and usage warnings. The design features blue and red text on a white background with a Novaplus logo.*

FDA Label Image

Adriamycin Injection 50 mg/25 mL Label (Adriamycin Doxorubicin HCl Injection Novaplus 6)

Label of Adriamycin 50 mg/25 mL injection, USP by Hikma Pharmaceuticals USA Inc. The label indicates a 25 mL single-dose vial of sterile isotonic solution intended for intravenous use only. It specifies an osmolality of 292 mosm/kg, contains 2 mg Doxorubicin HCl, USP injection chloride per mL, and includes directions for preparation and storage between 2°C and 8°C. The label also provides cautionary disposal instructions and mentions the product is manufactured by Thymoorgan Pharmaceuticals, Germany, and distributed by Hikma Pharmaceuticals USA Inc., Eatontown, NJ.*

FDA Label Image

Adriamycin Injection 200 mg/100 mL Label (Adriamycin Doxorubicin HCl Injection Novaplus 7)

Adriamycin (doxorubicin HCl) Injection, USP 200 mg/100 mL (2 mg/mL) in a multidose vial for intravenous use, labeled by Hikma Pharmaceuticals USA Inc. The vial contains sterile isotonic solution and is designed for multiple doses with a 100 mL volume.*

FDA Label Image

Representative Serialization Image (Adriamycin Doxorubicin HCl Injection Novaplus 8)

A rectangular pharmaceutical label including a QR code on the left and product identification details on the right. The text fields include GTIN, serial number (SN), expiration date (EXP), and lot number (LOT). The label does not show the product name, strength, dosage form, or manufacturer name visibly.*

FDA Label Image

Representative Serialization Image (Adriamycin Doxorubicin HCl Injection Novaplus 9)

A product label for Adriamycin by Hikma Pharmaceuticals USA Inc., featuring a 2D barcode on the left and text fields on the right showing lot number (ABCDE12345), expiration date (MMMYYYY), GTIN (00301234567896), and serial number (12345678901234). The label is designed for tracking and identification purposes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.